Safety profile of herbal medicines submitted for marketing authorization in Tanzania: a cross-sectional retrospective study
ConclusionAnalysis of the herbal medicine dossiers submitted showed major deficiencies of safety data to support MA. Manufactures need to provide evidence to support the safety of their products for evidence-based regulatory decisions and to avoid multiple reviews of the applications.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research
More News: African Health | Clinical Trials | Complementary Medicine | Herbs | Medical Devices | Pharmaceuticals | Study | Tanzania Health | Toxicology